JPRN-UMIN000051941招募中Unknown
A Large-scale Longitudinal Cohort Study to MaintainWell-Being and Functioning in Middle and Elderly Adults - A Large-scale Longitudinal Cohort Study to MaintainWell-Being and Functioning in Middle and Elderly Adults
niversity of Tsukuba0 个研究点目标入组 10,000 人开始时间: 2023年8月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 45years-old 至 89years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Persons who could not give consent to participate in this study 2) Those who are unable to confirm their own will due to dementia or other reasons 3) Persons who are judged by the principal investigator to be unsuitable to participate in this study
研究者
相似试验
进行中（未招募）
1 期
A long-term study to assess the safety and efficacy of nemolizumab (CD14152) in subjects with prurigo nodularis (PN)Prurigo NodularisEUCTR2019-004294-13-GBGalderma S.A.400
招募中
3 期
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis.chronic skin inflammation10014982atopic dermatitisNL-OMON54779Galderma15
招募中
3 期
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Prurigo NodularisNL-OMON54290Galderma10
进行中（未招募）
1 期
ong-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic DermatitisMedDRA version: 21.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersAtopic DermatitisEUCTR2019-001889-15-NLGalderma S.A.1,749
进行中（未招募）
1 期
ong-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic DermatitisAtopic DermatitisEUCTR2019-001889-15-EEGalderma S.A.1,749